![](/wp-content/uploads/2023/02/Screenshot-2023-02-01-at-11.43.02-AM.png)
$599
Novo Nordisk Q4 ’22 Earnings Update
Novo Nordisk hosted its Q4 ’22 earnings call (press release; slides) and provided updates across its business, including Wegovy/Ozempic supply, GLP-1RA market dynamics, new QW insulin icodec data, and more. Below, FENIX provides highlights and insights from the call.